Annals ofOncology

Volume: 7 - Number: 70 - December 15, 2007

Outstanding

Adjuvant therapy in colon cancer—what, when and how?

Neo-adjuvant chemotherapy for muscle-invasive bladder cancer: a look ahead

Maintenance rituximab following induction chemoimmunotherapy may prolong progression-free survival in mantle cell lymphoma: a pilot study from the Wisconsin Oncology Network

Treatment-related premature ovarian failure as a long-term complication after Hodgkin\'s lymphoma

Breast Cancer

Detailed analysis of a randomized phase III trial: can the tolerability of capecitabine plus docetaxel be improved without compromising its survival advantage?

Adjuvant systemic treatment of early breast cancer: the NORA study

Baseline MRI delivery characteristics predict change in invasive ductal breast carcinoma PET metabolism as a result of primary chemotherapy administration

cancer prevention

Colorectal cancer (CRC) screening using sigmoidoscopy followed by colonoscopy: a feasibility and efficacy study on a cancer institute based population

Editorial

KISS: the 2006 Annals of Oncology prizes

Management of neuromuscular dose limiting toxicity at the early stage of drug development

Epidemiology

Body size and laryngeal cancer risk

gastrointestinal tumors

A phase II study of high-dose bevacizumab in combination with irinotecan, 5-fluorouracil, leucovorin, as initial therapy for advanced colorectal cancer: results from the eastern cooperative oncology group study E2201

A phase II trial of neoadjuvant cisplatin–fluorouracil followed by postoperative intraperitoneal floxuridine–leucovorin in patients with locally advanced gastric cancer

Hematologic Malignancies

Maintenance rituximab following induction chemoimmunotherapy may prolong progression-free survival in mantle cell lymphoma: a pilot study from the Wisconsin Oncology Network

High incidence of non-neutropenic infections induced by rituximab plus fludarabine and associated with hypogammaglobulinemia: a frequently unrecognized and easily treatable complication

Treatment-related premature ovarian failure as a long-term complication after Hodgkin\'s lymphoma

Distinctive natural history in hepatitis C virus positive diffuse large B-cell lymphoma: analysis of 156 patients from northern Italy

Lung cancer

Phase II trial of temozolomide and cisplatin followed by whole brain radiotherapy in non-small-cell lung cancer patients with brain metastases: a GLOT-GFPC study

oncology practice

Factors that influence cancer patients\' anxiety following a medical consultation: impact of a communication skills training programme for physicians

phase I and pharmacokinetics

Phase I study of Aplidine in a dailyx5 one-hour infusion every 3 weeks in patients with solid tumors refractory to standard therapy. A National Cancer Institute of Canada Clinical Trials Group study: NCIC CTG IND 115

Reviews

Adjuvant therapy in colon cancer—what, when and how?

Neo-adjuvant chemotherapy for muscle-invasive bladder cancer: a look ahead

Supportive care

A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy